Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded related topic links: Ovarian cancer and MedlinePlus Genetics, expanding the related topics section on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedMinor wording updates were made to the PubMed publications note to clarify auto-fill behavior, and the revision indicator was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedFooter changes removed the government funding status notice and the 'Ovarian cancer - related topics' link. These removals do not affect the study details, enrollment criteria, or outcomes.SummaryDifference0.6%

- Check42 days agoChange DetectedNo significant changes to the core study details were observed; ancillary sections such as Publications and minor layout updates were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedRemoved MedlinePlus Genetics topic on ovarian cancer, reducing related content coverage.SummaryDifference0.2%

- Check71 days agoChange DetectedMajor update to core content: adds government funding notice and current operating status for NIH Clinical Center, and bumps revision from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.